Search over 3,000 reports

    Exondys 51- Drug Insights, 2017

    Exondys 51- Drug Insights, 2017
    Date: Nov, 2017
    Type: Pharmaceutical Industry Report
    Pages: 35
    Geography: Global
    Delivery Timeline: 48 hours
    SKU: DIDI0085
    DelveInsight's pharmaceuticals report, " Exondys 51 Drug Insights, 2017" highlights the Drug marketed details and the Global API Manufacturers details across the globe along with the location. The report covers the Global Market Assessment of the Exondys 51 covering the historical global sales and also provides the Exondys 51 sales estimation during the forecasted period (2017-2019). The report also covers the patents information and market exclusivity data, route of synthesis, market competition, and API manufacturers by country. In addition to this, the report also provides the SWOT analysis for Exondys 51 and emerging therapies in this space.

    Scope

    A review of the Exondys 51, based on information derived from company and industry-specific sources
    Product details on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification
    Coverage of the Drug Master Files and API Manufacturers by country
    Patent Expiry Timeline and Exclusivity Details
    Route of Synthesis of the API
    Forecasted Sales Figure from 2017-2019
    Market competition and emerging therapies
    SWOT Analysis
    DelveInsight Report Introduction
    Exondys 51- Overview
    Product Description
    Route of Synthesis
    Mechanism of Action
    Pharmacology
    Pharmacodynamics
    Pharmacokinetics
    Adverse Reactions
    Regulatory Milestones by Region
    Deals and Partnerships
    Product Details
    Exondys 51 Sales Assessment
    Historical Sales
    Forecasted Sales
    Patent Details by Region
    Company Financials
    Market Competition
    Emerging Therapies*
    Drug 1
    Product Description
    Research and Development
    Product Development Activities
    SWOT Analysis
    Appendix
    Methodology
    Consulting Services
    About DelveInsight
    Contact Us
    Disclaimer
    Table 1: Exondys 51, Description
    Table 2: Exondys 51, Product Details
    Table 3: Exondys 51, Historical Sales (in million USD)
    Table 4: Exondys 51, Forecasted Sales from 2017-2019 (in million USD)
    Table 5: Exondys 51, Patent Details
    Table 6: Company, Overview
    Table 7: Exondys 51 Major Competitors Exondys 51
    Table 8: Emerging Therapies
    Figure 1: Exondys 51, Historical Sales (in million USD)
    Figure 2: Exondys 51, Forecasted Sales from 2017-2019 (in million USD)
    Exondys 51
    Sarepta Therapeutics
    Duchenne muscular dystrophy
    DMD




    Exondys 51 Marketed Drugs Overview
    Exondys 51 Market Assessment
    Exondys 51 API Manufacturers/ Active Pharmaceutical Ingredients Manufacturers
    Exondys 51 US DMF
    Exondys 51 US Drug Master Files
    Exondys 51 Active Substance Master File/ EUDMF
    Exondys 51 Generic players
    Exondys 51 Patent Expiration
    Exondys 51 Patent Exclusivity
    Exondys 51 API Manufacturers
    Exondys 51 Global Forecasted Sales Figure
    Exondys 51 API Route of Synthesis
    Exondys 51 Market sales
    Exondys 51 SWOT Analysis
    Exondys 51 Pipeline
    • Single User License
      (20% Off)
      $1,000.00
      $800
    • Site License
      (30% Off)
      $2,000.00
      $1400
    • Global License
      (40% Off)
      $3,000.00
      $1800

    Contact Us

    Phone
    +91-11-45689769, +91 9650213330

    Email
    info@delveinsight.com

    Address
    New Delhi-110075, India

    Latest Tweets

    • Copyright © 2017 Delveinsight.
    • Sitemap